Digest Network Come funziona
Network
/
Società
Mi
Non verificato

Minerva Neurosciences, Inc

Di cosa scriviamo

FinanzaManagement/Organizzazione AziendaleMedicina Salute Benessere

7 comunicati stampa

Guarda tutti i comunicati
19/11/2025
Medicina Salute Benessere
Minerva Neurosciences Appoints Dr. Inderjit Kaul to the Company’s Board of Directors
Fonte
Minerva Neurosciences, Inc
Emittente
GLOBENEWSWIRE
1.00
0
05/11/2025
Medicina Salute Benessere
Management/Organizzazione Aziendale
Minerva Neurosciences Reports Third Quarter 2025 Financial Results and Business Updates
Fonte
Minerva Neurosciences, Inc
Emittente
GLOBENEWSWIRE
1.00
0
21/10/2025
Medicina Salute Benessere
Finanza
Minerva Neurosciences Announces Financing of up to $200 Million to Advance Roluperidone for the Treatment of Negative Symptoms in Patients with Schizophrenia Through a Phase 3 Confirmatory Trial and Resubmission of its New Drug Application and Preparation for US Commercial Launch, if Approved
Fonte
Minerva Neurosciences, Inc
Emittente
GLOBENEWSWIRE
1.00
0
14/08/2025
Medicina Salute Benessere
Management/Organizzazione Aziendale
Minerva Neurosciences Provides Business Updates and Second Quarter Financial Results
Fonte
Minerva Neurosciences, Inc
Emittente
GLOBENEWSWIRE
1.00
0
13/05/2025
Medicina Salute Benessere
Management/Organizzazione Aziendale
Minerva Neurosciences Reports First Quarter 2025 Financial Results and Business Updates
Fonte
Minerva Neurosciences, Inc
Emittente
GLOBENEWSWIRE
1.00
0
25/02/2025
Medicina Salute Benessere
Management/Organizzazione Aziendale
Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Business Updates
Fonte
Minerva Neurosciences, Inc
Emittente
GLOBENEWSWIRE
1.00
0
05/11/2024
Medicina Salute Benessere
Management/Organizzazione Aziendale
Minerva Neurosciences Reports Third Quarter 2024 Financial Results and Business Updates
Fonte
Minerva Neurosciences, Inc
Emittente
GLOBENEWSWIRE
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0